Seqirus AFLURIA QUADRIVALENT 0.5ml , 10 Pre-filled Syringes

$235.00

AFLURIA QUADRIVALENT

Description

AFLURIA QUADRIVALENT

Key Features

  • Administer as a 0.25-mL dose for patients 6 through 35 months, and as a 0.5-mL dose for patients 36 months through 8 years as 1 or 2* doses1
  • Demonstrated immunogenicity in children and adults1
  • Demonstrated safety profile1
  • Produced through traditional egg-based manufacturing1

*1 or 2 doses depends on vaccination history as per Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza with vaccines.